Grants & Projects per year
Fingerprint
Dive into the research topics where Tahmid Rahman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults with Elevated Lipoprotein(a) who have Established Atherosclerotic Cardi
Rahman, T. (PI) & Farooq, K. (CoPI)
08/16/24 → 12/9/26
Project: Research
-
Amgen: EVOLVE MI A Pragmatic Randomized Multicenter Trial of Evolocumab Administered Very Early to Reduce the Risk of Cardiovascular Events in Patients Hospitalized with Acute Myocardial Infarction
Chen, O. (PI), Alkhalil, A. (CoPI), Farooq, K. (CoPI), Rahman, T. (CoPI), Skopicki, H. A. (CoPI), Ibtida, I. (CoPI) & Maldonado, A. (CoPI)
12/1/23 → 05/17/27
Project: Research
-
A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Assessing the Impact of Olpasiran on Major Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease and Elevated Lipoprotein (a)
Chen, O. (PI), Rahman, T. (CoPI) & Skopicki, H. A. (CoPI)
09/11/23 → 05/26/27
Project: Research
-
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase IIIb Study Evaluating the Effect of Inclisiran on Atherosclerotic Plaque Progression Assessed by Coronary Computed Tomography Angiography (CCTA) in Participa
Chen, O. (PI), Rahman, T. (CoPI) & Skopicki, H. A. (CoPI)
Novartis Pharmaceuticals Corporation
04/10/23 → 01/23/27
Project: Research
-
A randomized, double-blind, placebo-controlled, multicenter trial, assessing the impact of inclisiran on major adverse cardiovascular events in participants with established cardiovascular disease (VICTORION-2 PREVENT)
Rahman, T. (PI), Chen, O. (CoPI) & Skopicki, H. A. (CoPI)
Novartis Pharmaceuticals Corporation
04/7/23 → 08/14/27
Project: Research
-
High-Grade Serous Ovarian Carcinoma Presenting as Cardiac Tamponade
Zhang, D. T., Hanna, K., Wu, M. & Rahman, T., Jul 1 2026, In: JACC: Case Reports. 31, 26, 108394.Research output: Contribution to journal › Article › peer-review
Open Access -
Lipoprotein(a) as a Predictor of Cardiovascular Risk in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review
Mojahedi, A., Chen, O., Skopicki, H. A., Rahman, T. & Sadeghian, A., Sep 2025, In: Reviews in Cardiovascular Medicine. 26, 9, 42784.Research output: Contribution to journal › Review article › peer-review
Open Access -
Safety and utility of mechanical circulatory support in patients with acute myocardial infarction complicated by cardiogenic shock: A systematic review and meta-analysis
Frye, J., Tao, M., Gupta, S., Gier, C., Masson, R., Rahman, T., Bench, T., Mann, N. & Tam, E., Jan 2025, In: Cardiovascular Revascularization Medicine. 70, p. 23-33 11 p.Research output: Contribution to journal › Article › peer-review
-
Primary Hypoalphalipoproteinemia With Significant Premature Atherosclerosis
Moussa, S., Price, J., Frye, J., Chen, O. & Rahman, T., Dec 4 2024, In: JACC: Case Reports. 29, 23, 102716.Research output: Contribution to journal › Article › peer-review
Open Access -
The role of structured inpatient lipid protocols in optimizing non-statin lipid lowering therapy: a review and single-center experience
Gier, C., Gilchrist, I., Fordham, M., Riordan, L., Milchan, E., Patel, N., Mohedi, A., Choudhury, S., Kits, T., Cohen, R., Doughtery, J., Reilly, J. P., Kalogeropoulos, A., Rahman, T. & Chen, O., 2024, In: Frontiers in Cardiovascular Medicine. 11, 1284562.Research output: Contribution to journal › Short survey › peer-review
Open Access